Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

PRFX
PRF Technologies Ltd.
stock NASDAQ

At Close
May 20, 2026 2:34:32 PM EDT
1.57USD+3.974%(+0.06)11,095
1.33Bid   1.94Ask   0.61Spread
Pre-market
May 20, 2026 9:20:30 AM EDT
1.52USD+0.662%(+0.01)262
After-hours
May 20, 2026 4:00:30 PM EDT
1.61USD+2.548%(+0.04)216
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 17, 2022
09:45AM EST  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Jan 3, 2022
09:46AM EST  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Dec 14, 2021
08:30AM EST  PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform, will be participating in the Benzinga All Access event taking place on December 16, 2021.   GlobeNewswire Inc
Nov 16, 2021
08:25AM EST  PainReform Net Loss $5.5M During 9 Months Ended Sept. 30, 2021   Benzinga
08:00AM EST  Reports continued progress towards commencingPhase 3 clinicaltrials   GlobeNewswire Inc
Oct 14, 2021
08:30AM EDT  PainReform to Present at Dawson James Securities 6th Annual Small   GlobeNewswire Inc
Aug 30, 2021
05:51AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.36 A.M. EDT).   RTTNews
Aug 27, 2021
06:44AM EDT  The following are some of the stocks making big moves in Friday's pre-market trading (as of 6.17 A.M. EDT).   RTTNews
Aug 16, 2021
08:00AM EDT  PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the second quarter ended June 30, 2021.   GlobeNewswire Inc
Jul 22, 2021
10:08AM EDT  Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates   Benzinga
Jul 21, 2021
10:21AM EDT  Shares of PainReform Ltd. (PRFX) are gaining over 11% on Wednesday morning despite no stock-related news to drive the shares. The U.S. stocks opened higher on Wednesday.   RTTNews
May 25, 2021
10:14AM EDT  Mid-Morning Market Update: Markets Edge Higher; AutoZone Tops Q3 Expectations   Benzinga
May 13, 2021
08:19AM EDT  PainReform Says Had Cash And Equivalents Of $19,424,000 As Of Mar. 31   Benzinga
08:15AM EDT  PainReform Provides Business Update for the First Quarter of 2021   GlobeNewswire Inc
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 14, 2021
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
Mar 18, 2021
09:18AM EDT  PainReform FY 2020 R&D Expenses $354K Vs $136K YoY   Benzinga
09:15AM EDT  PainReform Ltd. (Nasdaq: PRFX) (PainReform or the Company), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a year-end business update.   GlobeNewswire Inc
Mar 11, 2021
10:43AM EST  PainReform to Participate at M Vest LLC and Maxim Group LLC   GlobeNewswire Inc
Mar 8, 2021
09:00AM EST  PainReform Announces $6.0 Million Private Placement   GlobeNewswire Inc
Jan 7, 2021
08:30AM EST  PainReform Ltd. (Nasdaq: PRFX) (PainReform or the Company), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021.   GlobeNewswire Inc
Jan 6, 2021
08:38AM EST  PainReform Names Rita Keynan As VP Of Pharmaceutical Operations   RTTNews
08:30AM EST  PainReform Ltd. (Nasdaq: PRFX) (PainReform or the Company), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the appointment of Rita Keynan as Vice President of Pharmaceutical Operations.   GlobeNewswire Inc
Jan 4, 2021
08:38AM EST  PainReform Announces Appointment Of Lotus Clinical Research As CRO For Phase 3 Clinical Trial Of PRF-110   Benzinga
Nov 17, 2020
09:41AM EST  Stocks Trading Near 52-Week Lows Just After Open On Tuesday, Nov. 17, 2020: DQ, GDRX, FIIIU, PRFX, BCLI   Benzinga
Nov 11, 2020
07:38AM EST  The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap   Benzinga
Nov 6, 2020
02:45PM EST  Stocks Trading Near 52-Week Lows On Friday, Nov. 6, 2020: ASRT, KBLMU, PNRG, YGMZ, APRE, UHT, LAIX, CLI, CORR, ANIP, CCOI, KBLM, NYC, UTL, PEI, TIG, EYEG, PVL, ZSAN, TTNP, NBRV, SFT, WPG, IFS, COGT, LMNL, PRFX, GBT, FNHC, ASMB, EPZM, UCL   Benzinga
Nov 4, 2020
09:14AM EST  PainReform 13G From XT Holdings Shows 19.7% Stake In Co.   Benzinga
Sep 29, 2020
07:33AM EDT  PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials Of PRF-110   Benzinga
Sep 1, 2020
12:50PM EDT  PainReform 13G Filing From Sabby Mgmt. Shows 5.95% Stake In Co.   Benzinga
11:36AM EDT  PainReform Shares Open For Trade At $7.75; IPO Priced At $8/Share   Benzinga
09:25AM EDT  PainReform Shares Expected To Open For Quote At 11:25 a.m. EDT, Expected To Open For Trade After 11:35 a.m. EDT; IPO Priced At $8/Share   Benzinga
09:21AM EDT  PainReform Prices 2.5M Unit IPO At $8/Unit   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC